Medial Marketing and Media notes that while the overall call rates for the Pharma industry are decreasing, Novartis has increased their sales calls in the first half of 2010 by 7% compared to 2009. The industry overall has seen a 1% drop in sales calls.
Jason Fox, associate director of syndicated analytics at SDI, stated:
“With the number of pharmaceutical sales reps being scaled back dramatically over the last few years, it's no surprise that sales calls across the industry are also declining. However, companies with new drugs or newly approved indications for existing drugs need to get the information into the hands of physicians and other practitioners, and in-person calls are still the most popular type of promotion, outside of product sampling.”